Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells.

Abstract:

:We examined the expression of messenger RNA (mRNA) of the human inducible nitric oxide synthase (hiNOS) gene in a panel of human T-cell lines. Reverse transcriptase-polymerase chain reaction showed that human T-cell leukemia virus type-I (HTLV-I)-infected T-cell lines (MT-1, SLB-1, and C5/MJ) expressed mRNA for the hiNOS, but TL-Om1 or uninfected Jurkat, H9, and CCRF-CEM did not. The MT-1, SLB-1, and C5/MJ cell lines are infected with HTLV-I and express the viral transactivator Tax, whereas TL-Om1 cells, although derived from adult T-cell leukemia (ATL) leukemic cells, do not express Tax. There was, thus, a correlation between Tax and hiNOS mRNA expression. The transcriptional regulatory region of the hiNOS gene was activated by Tax in Jurkat, in which endogenous hiNOS is induced by Tax. Deletion analysis showed that the region of hiNOS encompassing nucleotides -159 to -111 contained the minimum Tax-responsive elements. Mutations in the NF-kappaB element at position -115 and -106 bp in the hiNOS promoter were still activated by Tax, and a Tax mutant defective for activation of the NF-kappaB pathway retained the ability to activate the hiNOS promoter. In addition, overexpression of the dominant-negative mutants of IkappaBalpha and I kappaBbeta failed to reduce Tax-induced activation of hiNOS gene. Furthermore, hiNOS mRNA was detected in leukemic cells from ATL patients. Our results show that the hiNOS promoter contains a minimum Tax-responsive element located between nucleotides -159 and -111, and imply that the expression of the hiNOS gene is involved in the pathogenesis of HTLV-I-associated diseases.

journal_name

Blood

journal_title

Blood

authors

Mori N,Nunokawa Y,Yamada Y,Ikeda S,Tomonaga M,Yamamoto N

subject

Has Abstract

pub_date

1999-10-15 00:00:00

pages

2862-70

issue

8

eissn

0006-4971

issn

1528-0020

journal_volume

94

pub_type

杂志文章

相关文献

BLOOD文献大全
  • The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion.

    abstract::Analysis of a growing number of chromosomal translocations in human tumors have shown that they frequently result in gene fusions encoding chimeric proteins. We have characterized the recurrent t(12;21)(p12;q22) translocation present in human B-lineage acute leukemias. This translocation fused two genes, tel and AML1,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Romana SP,Mauchauffé M,Le Coniat M,Chumakov I,Le Paslier D,Berger R,Bernard OA

    更新日期:1995-06-15 00:00:00

  • Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.

    abstract::Cutaneous T-cell lymphoma (CTCL) constitutes a malignant proliferative disease involving mostly CD4(+) T cells arising in the skin. Because of the lack of curative treatment options, interferons (IFN) have been introduced into the therapy of CTCL. Although effective even in advanced disease, response rates were about ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Stadler R,Otte HG,Luger T,Henz BM,Kühl P,Zwingers T,Sterry W

    更新日期:1998-11-15 00:00:00

  • Allogeneic marrow grafting for treatment of aplastic anemia: a follow-up on long-term survivors.

    abstract::Eleven of twenty-four patients with severe aplastic anemia given marrow grafts from HLA-identical siblings between October 1970 and March 1973 are alive with normal marrow function and continued evidence of engraftment 3-5 yr later. Ten have been leading normal lives with no immunosuppressive or other drug therapy sin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Storb R,Thomas ED,Buckner CD,Clift RA,Fefer A,Fernando LP,Giblett ER,Johnson FL,Neiman PE

    更新日期:1976-10-01 00:00:00

  • MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis.

    abstract::MicroRNAs (miRNAs) have emerged as important regulators of the immune system. However, despite this prominence, our understanding of the function of miRNAs in the early hematopoietic stages is incomplete. In this study, we found that miR-139-5p negatively regulated the proliferation of hematopoietic stem cells and pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-02-702464

    authors: Choi J,Kim YK,Park K,Nah J,Yoon SS,Kim DW,Kim VN,Seong RH

    更新日期:2016-10-27 00:00:00

  • Characterization and quantification of clonal heterogeneity among hematopoietic stem cells: a model-based approach.

    abstract::Hematopoietic stem cells (HSCs) show pronounced heterogeneity in self-renewal and differentiation behavior, which is reflected in their repopulation kinetics. Here, a single-cell-based mathematical model of HSC organization is used to examine the basis of HSC heterogeneity. Our modeling results, which are based on the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-155374

    authors: Roeder I,Horn K,Sieburg HB,Cho R,Muller-Sieburg C,Loeffler M

    更新日期:2008-12-15 00:00:00

  • Residual amounts of glycoproteins IIb and IIIa may be present in the platelets of most patients with Glanzmann's thrombasthenia.

    abstract::Glanzmann's thrombasthenia is an inherited bleeding disorder characterized by abnormalities of platelet membrane glycoproteins (GP) IIb and IIIa. Most patients, usually designated as type I, have been reported to have undetectable levels of GP IIb and GP IIIa with the assay used. We have used polyclonal rabbit antibod...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nurden AT,Didry D,Kieffer N,McEver RP

    更新日期:1985-04-01 00:00:00

  • AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage.

    abstract::We explored adeno-associated viral vector (AAV)-mediated gene transfer in the perinatal period in animal models of severe congenital factor VII (FVII) deficiency, a disease associated with early postnatal life-threatening hemorrhage. In young adult mice with plasma FVII < 1% of normal, a single tail vein administratio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-09-377630

    authors: Binny C,McIntosh J,Della Peruta M,Kymalainen H,Tuddenham EG,Buckley SM,Waddington SN,McVey JH,Spence Y,Morton CL,Thrasher AJ,Gray JT,Castellino FJ,Tarantal AF,Davidoff AM,Nathwani AC

    更新日期:2012-01-26 00:00:00

  • Fli1, Elf1, and Ets1 regulate the proximal promoter of the LMO2 gene in endothelial cells.

    abstract::Transcriptional control has been identified as a key mechanism regulating the formation and subsequent behavior of hematopoietic stem cells. We have used a comparative genomics approach to identify transcriptional regulatory elements of the LMO2 gene, a transcriptional cofactor originally identified through its involv...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-12-4755

    authors: Landry JR,Kinston S,Knezevic K,Donaldson IJ,Green AR,Göttgens B

    更新日期:2005-10-15 00:00:00

  • Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves gamma-globin activation by CREB1 and ATF-2.

    abstract::The histone deacetylase inhibitors (HDA-CIs) butyrate and trichostatin A activate gamma-globin expression via a p38 mitogen-activating protein kinase (MAPK)-dependent mechanism. We hypothesized that down-stream effectors of p38 MAPK, namely activating transcription factor-2 (ATF-2) and cyclic AMP response element (CRE...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-01-023713

    authors: Sangerman J,Lee MS,Yao X,Oteng E,Hsiao CH,Li W,Zein S,Ofori-Acquah SF,Pace BS

    更新日期:2006-11-15 00:00:00

  • A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.

    abstract::Inherited bleeding, thrombotic, and platelet disorders (BPDs) are diseases that affect ∼300 individuals per million births. With the exception of hemophilia and von Willebrand disease patients, a molecular analysis for patients with a BPD is often unavailable. Many specialized tests are usually required to reach a put...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-12-688267

    authors: Simeoni I,Stephens JC,Hu F,Deevi SV,Megy K,Bariana TK,Lentaigne C,Schulman S,Sivapalaratnam S,Vries MJ,Westbury SK,Greene D,Papadia S,Alessi MC,Attwood AP,Ballmaier M,Baynam G,Bermejo E,Bertoli M,Bray PF,Bury L,

    更新日期:2016-06-09 00:00:00

  • AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice.

    abstract::Emerging successful clinical data on gene therapy using adeno-associated viral (AAV) vector for hemophilia B (HB) showed that the risk of cellular immune response to vector capsid is clearly dose dependent. To decrease the vector dose, we explored AAV-8 (1-3 × 10(12) vg/kg) encoding a hyperfunctional factor IX (FIX-Pa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-588194

    authors: Crudele JM,Finn JD,Siner JI,Martin NB,Niemeyer GP,Zhou S,Mingozzi F,Lothrop CD Jr,Arruda VR

    更新日期:2015-03-05 00:00:00

  • Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis.

    abstract::Hemojuvelin (HJV) positively modulates the iron regulator hepcidin, and its mutations are the major cause of juvenile hemochromatosis (JH), a recessive disease leading to iron overload. Defective HJV reduces hepcidin up-regulation both in humans and in Hjv-deficient mice. To investigate the JH pathogenesis and the fun...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-041004

    authors: Silvestri L,Pagani A,Fazi C,Gerardi G,Levi S,Arosio P,Camaschella C

    更新日期:2007-05-15 00:00:00

  • Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells.

    abstract::All-trans-retinoic acid (ATRA) downregulates the expression of two cellular procoagulants, tissue factor (TF) and cancer procoagulant (CP), in human promyelocytic leukemia cells. To evaluate whether or not changes of the procoagulant activities (PCAs) may share mechanisms with the ATRA-induced cyto-differentiation pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Falanga A,Consonni R,Marchetti M,Locatelli G,Garattini E,Passerini CG,Gordon SG,Barbui T

    更新日期:1998-07-01 00:00:00

  • Ex vivo characterization and isolation of rare memory B cells with antigen tetramers.

    abstract::Studying human antigen-specific memory B cells has been challenging because of low frequencies in peripheral blood, slow proliferation, and lack of antibody secretion. Therefore, most studies have relied on conversion of memory B cells into antibody-secreting cells by in vitro culture. To facilitate direct ex vivo iso...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-341917

    authors: Franz B,May KF Jr,Dranoff G,Wucherpfennig K

    更新日期:2011-07-14 00:00:00

  • A single genetic origin for a common Caucasian risk factor for venous thrombosis.

    abstract::A common genetic risk factor for venous thrombosis among Caucasoid subpopulations is a polymorphism, nt G1691A, in blood coagulation factor V that replaces Arg506 with Gln and imparts resistance of factor Va to the anticoagulant, activated protein C. Haplotype analyses using six dimorphic sites in the factor V gene fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zivelin A,Griffin JH,Xu X,Pabinger I,Samama M,Conard J,Brenner B,Eldor A,Seligsohn U

    更新日期:1997-01-15 00:00:00

  • Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.

    abstract::The antibody-mediated delivery of therapeutic agents to sites of angiogenesis is an attractive strategy for anticancer therapy, but is largely unexplored in hematologic malignancies. In the present study, we show that the extra domain B (EDB) of fibronectin, a marker of angiogenesis, is expressed in B-cell non-Hodgkin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-160747

    authors: Schliemann C,Palumbo A,Zuberbühler K,Villa A,Kaspar M,Trachsel E,Klapper W,Menssen HD,Neri D

    更新日期:2009-03-05 00:00:00

  • Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation.

    abstract::The last 2 years have seen much excitement in the field of genetics with the identification of a formerly unappreciated level of "structural variation" within the normal human genome. Genetic structural variants include deletions, duplications, and inversions in addition to the recently discovered, copy number variant...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2006-06-030858

    authors: Mullally A,Ritz J

    更新日期:2007-02-15 00:00:00

  • Plasmic degradation of fibrin rapidly decreases platelet adhesion and spreading.

    abstract::Plasmin cleaves fibrin at or near sites involved in platelet recognition and may modulate platelet adhesion and spreading. Using an in vitro system, we have characterized the effects of limited plasmic degradation of polymerized fibrin on platelet adhesion and spreading. As shown by scanning electron microscopy, expos...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hamaguchi M,Bunce LA,Sporn LA,Francis CW

    更新日期:1994-08-15 00:00:00

  • Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.

    abstract::In utero hematopoietic stem cell transplantation (IUHSCTx) can achieve mixed hematopoietic chimerism and donor-specific tolerance without cytoreductive conditioning or immunosuppression. The primary limitation to the clinical application of IUHSCTx has been minimal donor cell engraftment, well below therapeutic levels...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-01-0016

    authors: Hayashi S,Peranteau WH,Shaaban AF,Flake AW

    更新日期:2002-08-01 00:00:00

  • Genetic expression of adenosine deaminase in human lymphoid malignancies.

    abstract::Adenosine deaminase (ADA) is an enzyme in the purine catabolic pathway that has been used as an enzymatic marker of T cell lymphoblastic malignancies due to its high specific activity in thymocytes and immature T cells. We have investigated whether the level of ADA activity in lymphoid leukemic cells correlates with t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gan TE,Dadonna PE,Mitchell BS

    更新日期:1987-05-01 00:00:00

  • Human CD8+ T cells store CXCR1 in a distinct intracellular compartment and up-regulate it rapidly to the cell surface upon activation.

    abstract::Activation and subsequent differentiation of naive CD8+ T cells lead to the development of memory subsets with distinct homing and effector capacities. On nonlymphoid homing subsets, expression of "inflammatory" chemokine receptors (such as CXCR3, CCR5, CX3CR1, and CXCR1) is believed to promote migration into sites of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-04-1366

    authors: Gasser O,Missiou A,Eken C,Hess C

    更新日期:2005-12-01 00:00:00

  • Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL.

    abstract::The induction of tumor cell differentiation represents an attractive strategy for the treatment of a wide range of malignancies. Differentiation of HL-60 promyelocytic leukemia cells towards neutrophils or monocytes has been shown to induce apoptotic cell death, which is inhibited by bcl-2 over-expression. However, th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Benito A,Silva M,Grillot D,Nuñez G,Fernández-Luna JL

    更新日期:1996-05-01 00:00:00

  • CD30: seeing is not always believing.

    abstract::Although most investigators are well aware of the incredible success of brentuximab vedotin in the treatment of patients with Hodgkin lymphoma (HL) and anaplastic large-cell lymphoma (ALCL), the study by Jacobsen and colleagues in this issue of Blood demonstrates surprising activity of this agent in patients with B-ce...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-01-622480

    authors: Blum KA

    更新日期:2015-02-26 00:00:00

  • Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors.

    abstract::The morphologic, immunophenotypic, genotypic, genomic, and functional features of an undifferentiated acute leukemia with stem cell features are reported. At light and electron microscopy, the leukemic population was represented by primitive progenitor cells with no evidence of differentiation. The blasts were CD34(+)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.12.4634

    authors: Testa U,Torelli GF,Riccioni R,Muta AO,Militi S,Annino L,Mariani G,Guarini A,Chiaretti S,Ritz J,Mandelli F,Peschle C,Foa R

    更新日期:2002-06-15 00:00:00

  • HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation.

    abstract::Dendritic cells (DCs) are antigen-presenting cells with the capacity to prime naive T cells for efficient cellular responses against pathogens such as HIV-1. DCs are also susceptible to HIV-1 infection, which may impair their ability to induce immunity. Here, we examined the ability of HIV-1-infected, in vitro-derived...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2314

    authors: Smed-Sörensen A,Loré K,Walther-Jallow L,Andersson J,Spetz AL

    更新日期:2004-11-01 00:00:00

  • Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells.

    abstract::Internal tandem duplication of the Fms-like tyrosine kinase-3 receptor (FLT3) internal tandem duplication (ITD) is found in 30% of acute myeloid leukemia (AML) and is associated with a poor outcome. In addition to tyrosine kinase inhibitors, therapeutic strategies that modulate the expression of FLT3-ITD are also prom...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-05-646497

    authors: Larrue C,Saland E,Boutzen H,Vergez F,David M,Joffre C,Hospital MA,Tamburini J,Delabesse E,Manenti S,Sarry JE,Récher C

    更新日期:2016-02-18 00:00:00

  • It takes a village.

    abstract::In this issue of Blood, Bhatia et al demonstrate the critical importance of an adherence to oral chemotherapy regimens in attaining cure for children with acute lymphoblastic leukemia (ALL) and identify race-specific determinants of adherence. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-05-576900

    authors: Winick N

    更新日期:2014-10-09 00:00:00

  • Therapy of severe aplastic anemia with anti-human thymocyte globulin and androgens: the effect of HLA-haploidentical marrow infusion.

    abstract::Fifty-four patients with severe aplastic anemia were treated with horse anti-human thymocyte globulin (ATG) and androgens. Thirty of these patients also received an infusion of HLA-haploidentical marrow cells. Only those patients having evidence of hematologic recovery within 3 mo after ATG therapy were considered res...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Doney K,Dahlberg SJ,Monroe D,Storb R,Buckner CD,Thomas ED

    更新日期:1984-02-01 00:00:00

  • Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement.

    abstract::Managing vitamin K antagonist (VKA) therapy is challenging in children because of a narrow therapeutic range and wide inter- and intra-individual variability in dose response. Only a few small studies have investigated the effect of nongenetic and genetic factors on the dose response to VKAs in children. In a cohort s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-07-365502

    authors: Moreau C,Bajolle F,Siguret V,Lasne D,Golmard JL,Elie C,Beaune P,Cheurfi R,Bonnet D,Loriot MA

    更新日期:2012-01-19 00:00:00

  • Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells.

    abstract::We studied the cell kill induced by granulocyte-macrophage colony-stimulating factor (GM-CSF ) fused to Diphtheria Toxin (DT-GM-CSF ) in acute myeloid leukemia (AML) samples and in populations of normal primitive hemopoietic progenitor cells. AML samples from three patients were incubated in vitro with 100 ng/mL DT-GM...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Terpstra W,Rozemuller H,Breems DA,Rombouts EJ,Prins A,FitzGerald DJ,Kreitman RJ,Wielenga JJ,Ploemacher RE,Löwenberg B,Hagenbeek A,Martens AC

    更新日期:1997-11-01 00:00:00